| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/24/2013 | WO2013010950A1 PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS, THEIR PREPARATION AND USE AS SIGMA LIGANDS |
| 01/24/2013 | WO2013010904A1 Novel substituted indole derivatives as gamma secretase modulators |
| 01/24/2013 | WO2013010880A1 New crth2 antagonists |
| 01/24/2013 | WO2013010869A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors |
| 01/24/2013 | WO2013010868A1 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors |
| 01/24/2013 | WO2013010382A1 Heterocyclic substituted pyrimidine compound |
| 01/24/2013 | WO2012148246A3 A preparation method of sitagliptin |
| 01/24/2013 | WO2012010663A9 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/24/2013 | US20130023661 Fluorinating reagents with (perfluoralkyl) fluorophosphate anion |
| 01/24/2013 | US20130023568 Benzimidazole Derivatives And Their Pharmaceutical Compositions And Uses |
| 01/24/2013 | US20130023531 Pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors |
| 01/24/2013 | US20130023530 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023524 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 01/24/2013 | US20130023523 Pyridazino[4,5-d]pyrimidin-5(6h)-one inhibitors of kinases |
| 01/24/2013 | US20130023514 Substituted pyrrolotriazines as protein kinase inhibitors |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023499 Certain substituted amides, method of making, and method of use thereof |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130019949 Compounds for organic thin-film solar cells and organic thin-film solar cells |
| 01/24/2013 | CA2842505A1 Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands |
| 01/24/2013 | CA2842187A1 Heterocyclic compounds and uses thereof |
| 01/24/2013 | CA2841887A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk - inhibitors |
| 01/24/2013 | CA2841886A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors |
| 01/24/2013 | CA2841102A1 Novel substituted indole derivatives as gamma secretase modulators |
| 01/23/2013 | EP2548878A1 Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands |
| 01/23/2013 | EP2548877A1 4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors |
| 01/23/2013 | EP2548876A1 New CRTh2 antagonists |
| 01/23/2013 | EP2548558A1 Nitrogen-containing condensed heterocyclic as inhibitors of bruton's tyrosine kinase |
| 01/23/2013 | EP2547684A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 01/23/2013 | EP2547683A1 Method of preparing sitagliptin |
| 01/23/2013 | EP2547682A1 Solid state forms of sitagliptin salts |
| 01/23/2013 | EP2547681A1 Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3 -methyl-4,10-dihydro-3h-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide |
| 01/23/2013 | EP2547680A1 Imidazopyrazines |
| 01/23/2013 | EP2547678A1 Anti-infective compounds |
| 01/23/2013 | EP2385945B1 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892768A Substituted pyrrolo-aminopyrimidine compounds |
| 01/23/2013 | CN102888217A Porphyrin iron fluorescent material |
| 01/23/2013 | CN102887947A Process for producing micromolecule hemepeptide, heme iron and plasma proteins by using duck blood as raw material |
| 01/23/2013 | CN102887902A Preparation process for synthesizing high-purity Pemedolac |
| 01/23/2013 | CN102887901A Acyclic nucleotide analogs as well as preparation method and application thereof |
| 01/23/2013 | CN102887900A Inhibitors of bruton's tyrosine kinase |
| 01/23/2013 | CN102887895A Pyridopyrimidine mammalian target of rapamycin (mTOR) inhibitor |
| 01/23/2013 | CN101578286B Diketopyrrolopyrrole cocrystals with high transparency |
| 01/23/2013 | CN101501035B Pyrimidine derivative as P13K inhibitor and use thereof |
| 01/23/2013 | CN101410398B Improved process for producing carbapenem compound |
| 01/23/2013 | CN101233134B 制备泛昔洛韦和其它嘌呤衍生物 Preparation of famciclovir and other purine derivatives |
| 01/22/2013 | US8357698 Diacyl indazole derivatives as lipase and phospholipase inhibitors |
| 01/22/2013 | US8357694 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds |
| 01/22/2013 | US8357686 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/22/2013 | CA2452644C Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 01/22/2013 | CA2325629C Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide |
| 01/17/2013 | WO2013009140A2 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | WO2013008872A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | WO2013008247A1 Process for preparation of (dl) -norepinephrine acid addition salt, a key intermediate of (r) - (-) - norepinephrine |
| 01/17/2013 | WO2013008217A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | WO2013008095A1 Novel pyrrolo pyrimidine derivatives |
| 01/17/2013 | WO2013007168A1 Preparation and use of pyrrole and dihydropyrrole fused ring compound having insecticidal activity |
| 01/17/2013 | US20130018202 4-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives |
| 01/17/2013 | US20130018063 Organic compounds |
| 01/17/2013 | US20130018060 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018048 Oxazole derivatives useful as modulators of faah |
| 01/17/2013 | US20130018040 Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases |
| 01/17/2013 | US20130018038 Chemical compounds |
| 01/17/2013 | US20130018035 Compounds useful as inhibitors of atr kinase |
| 01/17/2013 | US20130018034 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 01/17/2013 | US20130018032 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | US20130017273 Compounds useful as inhibitors of atr kinase |
| 01/17/2013 | US20130017170 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/17/2013 | CA2841932A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | CA2841897A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | CA2841252A1 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | CA2841111A1 Novel pyrrolo pyrimidine derivatives |
| 01/16/2013 | EP2546256A2 Process for the synthesis of intermediates compounds useful for the preparation of E1 activity activating enzyme inhibitors |
| 01/16/2013 | EP2546255A1 Benzazepine compound |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545058A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/16/2013 | EP2545057A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 01/16/2013 | EP2545056A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 01/16/2013 | EP2545055A1 Imidazo [1, 2 -a]pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases |
| 01/16/2013 | CN102884066A Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 01/16/2013 | CN102884065A Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 01/16/2013 | CN102884064A Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof |
| 01/16/2013 | CN102884063A Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
| 01/16/2013 | CN102884062A Aminopyrimidine kinase inhibitors |
| 01/16/2013 | CN102884057A 雄激素受体调节剂及其用途 Androgen receptor modulators and their use |
| 01/16/2013 | CN102884044A Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 01/16/2013 | CN102875557A Tetranitroglycoluril dipolymer, preparation method and application |
| 01/16/2013 | CN102875556A (4S)-1-substituted-2,5-diazabicyclo[2,2,1] heptane derivative and preparation method thereof |
| 01/16/2013 | CN102875555A Synthetic method of JAK (janus kinase) inhibitor Tofacitinib |
| 01/16/2013 | CN102875537A Novel preparation method of antithrombosis medicine |
| 01/16/2013 | CN102875441A Plexxikon inc |
| 01/16/2013 | CN102872914A Chiral double-oxazoline amino metal catalyst, as well as preparation method and application thereof |
| 01/16/2013 | CN102115475B Method for synthesizing pyrazolo[3,4-d]pyrimidine derivative by two steps |
| 01/16/2013 | CN101967149B Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of nitryl and preparation and application |